SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    H. Toktas, E. Okur, U. Dundar, A. Dikici, O. K. Kahveci, Infliximab has no apparent effect in the inner ear hearing function of patients with rheumatoid arthritis and ankylosing spondylitis, Clinical Rheumatology, 2014,

    CrossRef

  2. 2
    Victoria Bejarano, Elizabeth Hensor, Michael Green, Glenn Haugeberg, Andrew K. Brown, Maya H. Buch, Paul Emery, Philip G. Conaghan, Relationship between early bone mineral density changes and long-term function and radiographic progression in rheumatoid arthritis, Arthritis Care & Research, 2012, 64, 1
  3. 3
    Greg Tesch, Shashi Amur, John T. Schousboe, Jeffrey N. Siegel, Lawrence J. Lesko, Jane P. F. Bai, Successes Achieved and Challenges Ahead in Translating Biomarkers into Clinical Applications, The AAPS Journal, 2010, 12, 3, 243

    CrossRef

  4. 4
    Srilakshmi M. Sharma, Achim R. Nestel, Richard W. J. Lee, Andrew D. Dick, Clinical Review: Anti-TNFα Therapies in Uveitis: Perspective on 5 Years of Clinical Experience, Ocular Immunology and Inflammation, 2009, 17, 6, 403

    CrossRef

  5. 5
    Richard J. Wakefield, Jane E. Freeston, Elizabeth M. A. Hensor, Domini Bryer, Mark A. Quinn, Paul Emery, Delay in imaging versus clinical response: A rationale for prolonged treatment with anti–tumor necrosis factor medication in early rheumatoid arthritis, Arthritis Care & Research, 2007, 57, 8
  6. 6
    MD Hyzy, J Slavotinek, MD Smith, Role of ultrasound in assessment of early rheumatoid arthritis, Australasian Radiology, 2007, 51, 2
  7. 7
    Karim Raza, Caitriona E. Buckley, Mike Salmon, Christopher D. Buckley, Treating very early rheumatoid arthritis, Best Practice & Research Clinical Rheumatology, 2006, 20, 5, 849

    CrossRef

  8. 8
    Jeska K. de Vries-Bouwstra, Ben A.C. Dijkmans, Ferdinand C. Breedveld, Biologics in Early Rheumatoid Arthritis, Rheumatic Disease Clinics of North America, 2005, 31, 4, 745

    CrossRef

  9. 9
    Helen I Keen, Paul Emery, How should we manage early rheumatoid arthritis? From imaging to intervention, Current Opinion in Rheumatology, 2005, 17, 3, 280

    CrossRef

  10. 10
    Karim Raza, Mike Salmon, Christopher D Buckley, Treatment of early rheumatoid arthritis, Therapy, 2005, 2, 4, 659

    CrossRef

  11. 11
    Karim Raza, Mike Salmon, Christopher D Buckley, Treatment of early rheumatoid arthritis, Therapy, 2005, 2, 4, 659

    CrossRef

  12. 12
    Bénédicte Mugnier, Jean Roudier, Facteurs prédictifs de réponse aux traitements par anticorps anti-TNFα dans la polyarthrite rhumatoïde : vers une utilisation rationnelle des biothérapies, Revue du Rhumatisme, 2004, 71, 3, 175

    CrossRef

  13. 13
    Bénédicte Mugnier, Jean Roudier, Factors predicting responsiveness to anti-TNFα therapy in patients with rheumatoid arthritis: using biotherapies rationally, Joint Bone Spine, 2004, 71, 2, 91

    CrossRef

  14. 14
    Amy C. Cannella, James R. OʼDell, Is there still a role for traditional disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis?, Current Opinion in Rheumatology, 2003, 15, 3, 185

    CrossRef